Company Filing History:
Years Active: 2012
Title: Inventor Spotlight: Maria De Les Neus Mesquida-Estevez
Introduction
Maria De Les Neus Mesquida-Estevez is an innovative inventor based in Barcelona, Spain. With a remarkable number of two patents to his name, he is recognized for his contributions to the field of medicinal chemistry.
Latest Patents
His latest patents include two significant innovations. The first is focused on "Indene derivatives, their preparation and use as medicaments." This invention details new indene derivatives characterized by a general formula (I), along with the procedures for their preparation and applications as medicaments. The compounds outlined in this patent have demonstrated affinity for 5-HT receptors, making them useful for treating diseases mediated by these receptors.
The second patent concerns "Substituted indanyl sulfonamide compounds, their preparation and use as medicaments." Similar to his first patent, this innovation introduces new indanyl sulfonamide compounds, also defined by a general formula (I). These compounds are prepared and utilized as medicines, again displaying significant affinity for 5-HT receptors, which suggests their efficacy in treating related medical conditions.
Career Highlights
Throughout his career, Maria De Les Neus Mesquida-Estevez has made notable advancements in pharmaceutical innovations. He has worked with esteemed organizations including Laboratories del Sr. Esteve, S.A. and Laboratorios del Dr. Esteve S.A., where he applied his expertise in the development of medicaments.
Collaborations
Collaboration plays a crucial role in the innovative process for Mesquida-Estevez. He has had the opportunity to work alongside talented individuals, including Maria De Las Ermitas Alcalde-Pais and Jordi Frigola-Constansa, fostering a creative environment that encourages groundbreaking research and solutions.
Conclusion
Maria De Les Neus Mesquida-Estevez stands out in the realm of inventors with his significant contributions to medicinal chemistry. His pioneering patents not only highlight the potential of indene and indanyl sulfonamide compounds but also promise advancements in therapeutic applications for diseases influenced by 5-HT receptors. His work continues to inspire innovation within the pharmaceutical industry and exemplifies the vital role of inventors in shaping the future of medicine.